Home » ETF » BBH

BBH - VanEck Vectors Biotech ETF

Stock Price: $183.44 USD -0.21 (-0.11%)
Updated Apr 20, 2021 4:00 PM EDT - Market closed
After-hours: $181.50 -1.94 (-1.06%) Apr 20, 4:59 PM
Assets $518.86M
NAV $183.90
Expense Ratio 0.35%
PE Ratio 26.71
Beta (5Y) 0.90
Dividend (ttm) $0.61
Dividend Yield 0.33%
Ex-Dividend Date Dec 21, 2020
1-Year Return -
Trading Day April 20
Last Price $183.44
Previous Close $183.65
Change ($) -0.21
Change (%) -0.11%
Day's Open 182.58
Day's Range 181.31 - 185.00
Day's Volume 12,151
52-Week Range 144.21 - 197.28

Fund Description

The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS® US Listed Biotech 25 Index. The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.

Asset Class
Equity
Sector
Biotech
Region
North America
Inception Date
Dec 20, 2011
Exchange
NASDAQ
Ticker Symbol
BBH
Index Tracked
MVIS US Listed Biotech 25 Index

Top 10 Holdings

54.84% of assets
NameSymbolWeight
AmgenAMGN9.89%
ModernaMRNA5.76%
IQVIA HoldingsIQV5.25%
Gilead SciencesGILD5.08%
Alexion PharmaceuticalsALXN4.96%
Regeneron PharmaceuticalsREGN4.92%
Novavax Incn/a4.89%
BiogenBIIB4.72%
Vertex PharmaceuticalsVRTX4.71%
IlluminaILMN4.66%
View More Holdings

Dividends

Ex-DividendAmountPay Date
Dec 21, 2020$0.6079Dec 28, 2020
Dec 23, 2019$0.416Dec 30, 2019
Dec 20, 2018$0.551Dec 27, 2018
Dec 18, 2017$0.683Dec 22, 2017
Dec 19, 2016$0.26Dec 23, 2016
Dec 21, 2015$0.34Dec 28, 2015
Full Dividend History

News

Hide News
  • All
  • Videos
  • Conversation

Some biotech and pharmaceutical ETFs are gaining on Tuesday despite news that Johnson and Johnson's coronavirus vaccine has been halted in over two dozen states, after the Food and Drug Administration r...

Other tickers mentioned: FHLC, IEIH, IHE
1 week ago - ETF Trends

Investors are closely tracking the progress in coronavirus vaccine development amid the pandemic's renewed resurgence with multiple mutants.

Other tickers mentioned: AZN, BNTX, BTEC, FBT, IBB, MRNA, NVAX ...
1 week ago - Zacks Investment Research

The United States and China have been locking horns when it comes to technological advances. ETF investors looking to capitalize on strength in U.S. biotech should give the VanEck Vectors® Biotech ETF (...

1 month ago - ETF Trends

Investors looking to reduce the risk of owning some of 2021's best stocks might consider these 10 ETFs to buy instead. The post 10 ETFs to Buy to Mimic 2021's Best Stock Picks appeared first on Investor...

Other tickers mentioned: ARKW, GOAU, MLPA, ONLN, PSCD, QCLN, RHS ...
1 month ago - InvestorPlace

Biotechnology sector-related exchange traded funds strengthened after Illumina (NasdaqGS: ILMN) announced better-than-expected quarterly earnings and an optimistic 2021 outlook. On Friday, the VanEck Ve...

Other tickers mentioned: IBB
2 months ago - ETF Trends

2020 saw a lot of initial public offerings (IPOs) put on hold thanks to Covid-19. Now that a global vaccine rollout is underway, biotech IPOs are hitting the markets and boosting the VanEck Vectors® Bio...

2 months ago - ETF Trends

Let's take a look at some ETFs with exposure to major players in the U.S. biotech industry post their fourth-quarter earnings releases amid the coronavirus crisis.

Other tickers mentioned: IBB, XBI
2 months ago - Zacks Investment Research

The biotech space had an impressive run on the bourses in 2020 as the coronavirus pandemic triggered a race to roll out vaccine and treatment.

Other tickers mentioned: ARKG, BNTX, BTEC, CNCR, FBT, IBB, PBE ...
3 months ago - Zacks Investment Research

By Michael Cohick, Senior ETF Product Manager, VanEck Recent positive developments in COVID-19 vaccines have spurred a wave of market exuberance, lifting share prices of biotech companies at the forefro...

3 months ago - ETF Trends

AstraZeneca has agreed to buy rare-disease specialist Alexion Pharmaceuticals for $39 billion. The deal would represent the biggest transaction in pharmaceuticals since 2019.

Other tickers mentioned: FBT, PBE, PJP, PPH
4 months ago - Zacks Investment Research

The biotechnology space is always fertile territory for mergers and acquisitions, and that theme was on display over the weekend when AstraZeneca (NYSE: AZN) announced a $39-billion takeover of Alexion ...

Other tickers mentioned: FBT, PBE
4 months ago - Benzinga

November has been a big month for stock and biotech ETFs, and with the Federal Aviation Administration announcing that it supported the “first mass air shipment” of coronavirus vaccines on Friday, pharm...

Other tickers mentioned: IBB, XBI
4 months ago - ETF Trends

Healthcare stocks and ETFs are continuing to outperform as investors are optimistic about an upcoming vaccine for the coronavirus, which has been a blight on the globe since early this year. There has b...

Other tickers mentioned: CNCR, IBB
4 months ago - ETF Trends

The COVID-19 pandemic has given way to new technological innovations in the biotechnology sector with respect to creating a vaccine. ETF investors looking for a play that can take them well into 2021 mi...

5 months ago - ETF Trends

Monday saw stocks and index ETFs surge, after the announcement from Pfizer that the pharmaceutical giant had a vaccine candidate with an over 90% effectiveness in clinical trials. Now another biotech, M...

Other tickers mentioned: CNCR, IBB
5 months ago - ETF Trends

Let's take a look at some ETFs with exposure to major players in the U.S. biotech industry, post their third-quarter earnings releases amid the coronavirus crisis.

Other tickers mentioned: IBB, XBI
5 months ago - Zacks Investment Research

As coronavirus cases start to tick upwards once more, the race to create a vaccine will only intensify, boding well for the biotechnology sector. ETF investors may want to keep an eye on biotech funds, ...

Other tickers mentioned: ARKG, FBT, XBI
5 months ago - ETF Trends

With Regeneron Pharmaceuticals and Eli Lilly & Company requesting the FDA for an Emergency Use Authorization for their antibody therapy treatments, the biotech space is filled with optimism.

Other tickers mentioned: ARKG, IBB, PBE, XBI
6 months ago - Zacks Investment Research

The progress in Trump's health condition and his treatment protocols are continuously under the purview of market participants and are impacting Wall Street movements.

Other tickers mentioned: ARKG, IBB, PBE, XBI
6 months ago - Zacks Investment Research

The race to introduce vaccine and treatment of coronavirus is opening up opportunities, making the biotech sector a prospective space for investments.

Other tickers mentioned: ARKG, IBB, XBI
6 months ago - Zacks Investment Research

Biotech Sector Chart The broad stock market’s two day rally saw biotech stocks surge higher. In particular, the reversal in Biotech Sector ETFs BBH and XBI looks to be bullish.

Other tickers mentioned: XBI
6 months ago - See It Market

Johnson & Johnson's entry into the late-stage trials has increased optimism in the coronavirus vaccine development.

Other tickers mentioned: ARKG, FBT, IBB, XBI
6 months ago - Zacks Investment Research

Nine vaccine developers have jointly pledged to observe high ethical standards in conducting clinical studies and manufacturing of vaccines.

Other tickers mentioned: ARKG, FBT, IBB, XBI
7 months ago - Zacks Investment Research

AstraZeneca's initiation of a phase III study has heated up competition to bring a coronavirus vaccine to the markets.

Other tickers mentioned: ARKG, FBT, IBB, XBI
7 months ago - Zacks Investment Research

For the first four months of the market’s cornavirus recovery, one of the key themes was the dominance of biotech.

Other tickers mentioned: PPH
7 months ago - Benzinga

Per the latest data from an early stage clinical trial, Moderna's experimental coronavirus vaccine is successfully producing neutralizing antibodies and T-cells in older adults.

Other tickers mentioned: BTEC, CNCR, GERM, IBB, IDNA, XBI
7 months ago - Zacks Investment Research

Stock indexes and ETFs rocketed higher and are continuing the uptrend in trading Wednesday after Moderna said its coronavirus vaccine generated antibodies in elderly patients for the first time, creatin...

Other tickers mentioned: CNCR, IBB, XBI
7 months ago - ETF Trends

Coronavirus treatment: FDA authorizes convalescent plasma for COVID-19 use

YouTube video

Yahoo Finance's Anjalee Khemlani reports on the FDA's approval on the use of convalescent plasma to treat COVID-19.

Other tickers mentioned: IBB, XBI
7 months ago - Yahoo Finance

Let's take a look at some ETFs with exposure to major players in the U.S. biotech industry, post their Q2 earnings releases amid the coronavirus crisis.

Other tickers mentioned: IBB, XBI
8 months ago - Zacks Investment Research

Two major vaccine developers' entrance into the final stage trials is expected to boost investor optimism.

Other tickers mentioned: ARKG, FBT, IBB, XBI
8 months ago - Zacks Investment Research

The race to find a coronavirus vaccine is heating up as the latest positive data from progress in trials are being published.

Other tickers mentioned: ARKG, FBT, IBB, XBI
8 months ago - Zacks Investment Research

Moderna plans to begin the Phase 3 study of mRNA-1273 this month.

Other tickers mentioned: MRNA, BTEC, CNCR, FBT, GERM, IBB, IDNA ...
9 months ago - Zacks Investment Research

Stock futures rocketed higher and are continuing the uptrend in overnight trading on Tuesday after Moderna said its coronavirus vaccine generated antibodies in all patients in an early trial, creating o...

Other tickers mentioned: BTEC, CNCR, IBB, XBI
9 months ago - ETF Trends

As the coronavirus outbreak continues to aggravate, investors are eyeing developments in vaccine or treatments to combat the pandemic.

Other tickers mentioned: ARKG, FBT, IBB, XBI
9 months ago - Zacks Investment Research

With a slew of news to start off the month and quarter, biotech equities and ETFs are moving higher on Wednesday with optimism over developments on the coronavirus vaccine front. The Dow Jones Industria...

Other tickers mentioned: BBC, IBB
9 months ago - ETF Trends

In a sea of red stocks on Wednesday, as fear grips markets due to another spike in coronavirus cases throughout the country, Gilead Sciences is one of the few bright spots in the stock market.

Other tickers mentioned: IBB, PBE
9 months ago - ETF Trends

In the continuing quest to find a vaccine for the coronavirus, the World Health Organization announced Wednesday it is dropping hydroxychloroquine, the malaria drug backed by President Trump, who claims...

Other tickers mentioned: FBT
10 months ago - ETF Trends

In the race to develop a coronavirus vaccine, AstraZeneca (NYSE: AZN) and Gilead Sciences (NASDAQ: GILD) are two of the leading contenders and that could be the starting point of a massive marriage, acc...

Other tickers mentioned: DVP, IBB
10 months ago - Benzinga

Here we take a look at how the latest updates on drugs, antibody therapies and vaccines targeted at winning the coronavirus battle can affect biotech ETFs.

Other tickers mentioned: ARKG, FBT, IBB, XBI
10 months ago - Zacks Investment Research

Here we highlight some ETF areas that will make interesting investment options for investors amid the coronavirus crisis.

Other tickers mentioned: BOTZ, CLIX, CLOU, IBB, IBUY, IRBO, JETS ...
10 months ago - Zacks Investment Research

From VanEck Global With the COVID-19 pandemic showing few signs of easing, biotech companies are racing to meet soaring demand for treatments, vaccines and testing kits. This is helping to drive renewed...

10 months ago - ETF Trends

Novavax's latest progress in the Covid-19 vaccine development brings optimism to the Wall Street.

Other tickers mentioned: ARKG, FBT, IBB, XBI
10 months ago - Zacks Investment Research

There’s no denying biotechnology ETFs are benefiting from the race to cure and treat and the novel coronavirus. Just look at the VanEck Vectors Biotech ETF (BBH), which is higher by more than 7% over ju...

10 months ago - ETF Trends

With the race to find a vaccine for the coronavirus, now drugmaker AstraZeneca is the latest to receive funding to generate a panacea.

Other tickers mentioned: AZN, CNCR, IBB, XBI
11 months ago - ETF Trends

Positive data on early-stage coronavirus vaccine trial sent Moderna shares surging.

Other tickers mentioned: IBB, XBI
11 months ago - Zacks Investment Research

Let's take a look at some ETFs with exposure to major players in the U.S. biotech industry, post their Q1 earnings releases amid the coronavirus crisis.

Other tickers mentioned: IBB, XBI
11 months ago - Zacks Investment Research

Rising investor interest in coronavirus related stocks will benefit these ETFs

Other tickers mentioned: IBB, XBI
11 months ago - Zacks Investment Research

As the coronavirus continues to spread, the latest positive data on remdesivir is some relief in such challenging times.

Other tickers mentioned: IBB, PBE, XBI
11 months ago - Zacks Investment Research

The healthcare space is heated up with players rushing to come up with a vaccine for COVID-19.

Other tickers mentioned: IBB, VHT, XBI, XLV
11 months ago - Zacks Investment Research

Biotech and healthcare ETFs were pretty stable on Apr 23 despite the news that Gilead's Remdesivir failed to improve Covid-19 patients' condition.

Other tickers mentioned: CNCR, FBT, IBB, IDNA, IHE, IHF, PBE ...
11 months ago - Zacks Investment Research